Intercellular communication in tissue remodelling of chronic lung diseases

E-poster session
Chairs: T. Maes (Ghent, Belgium), A. Fabre (Dublin 4, Ireland)

Association between microbiome and plasma proteome profile in COPD M. Yavari Ramsheh (Leicester, United Kingdom), T. Cao (Leicester, United Kingdom), O. Elneima (Leicester, United Kingdom), H. Mcauley (Leicester, United Kingdom), V. Mistry (Leicester, United Kingdom), K. Haldar (Leicester, United Kingdom), M. Barer (Leicester, United Kingdom), L. Ng (Leicester, United Kingdom), C. Brightling (Leicester, United Kingdom)
Mouse tracheal epithelial cells (mTECs) for the study of influenza A infectio> F. ALJuhani (Sheffield , United Kingdom), P. Anujan (London , United Kingdom), L. Bingle (Sheffield , United Kingdom), C. Bingle (Sheffield , United Kingdom)
Comparison of the effectiveness of azithromycin and budesonide versus theophylline and budesonide in the suppression of pro-inflammatory cytokines in patients with COPD A. Kadushkin (Minsk, Belarus), A. Tahanovich (Minsk, Belarus), T. Kolesnikova (Minsk, Belarus), E. Hodosovskaya (Minsk, Belarus)
Evaluation of mitochondrial dysfunction of mononuclear leukocytes of smokers and ex-smokers in COPD exacerbation E. Belskikh (Ryazan, Russian Federation), S. Akhmedova (Ryazan, Russian Federation), N. Popko (Ryazan, Russian Federation), O. Uryasev (Ryazan, Russian Federation), V. Zvyagina (Ryazan, Russian Federation), O. Zhurina (Ryazan, Russian Federation), V. Demikhov (Ryazan, Russian Federation)
Lung tissue multi-omics integration in copd N. Olvera (BARCELONA, Spain), G. Noell (Barcelona, Spain), S. Casas-Recasens (Barcelona, Spain), A. López-Giraldo (Barcelona, Spain), A. Guirao (Barcelona, Spain), A. Agusti (Barcelona, Spain), M. Faner Canet (Barcelona, Spain)
THE GENE SIGNATURE OF LUNGS FROM GUINEA PIGS EXPOSED TO CIGARETTE SMOKE OVERLAPS WITH THAT OF HUMAN WITH COPD A. Bosacoma (Barcelona, Spain), D. Aguilar (Barcelona, Spain), T. Paul (Barcelona, Spain), I. Blanco (Barcelona, Spain), O. Tura-Ceide (Barcelona, Spain), J. Barberà (Barcelona, Spain), V. Peinado (Barcelona, Spain)
Copy Number Variation (CNV) in Chronic Obstructive Pulmonary Disease (COPD) with and without ongoing smoking A. Trivedi (New Delhi (Delhi), India), A. Talwar (New Delhi (Delhi), India), M. Sampath (New Delhi (Delhi), India), D. Ghosh (New Delhi (Delhi), India), R. Guleria (New Delhi (Delhi), India), G. Bade (New Delhi (Delhi), India)
Extracellular vesicle-derived muscle-specific miRNAs for the characterization of group B COPD patients T. Neri (Pisa (PI), Italy), S. Carpi (Pisa (PI), Italy), B. Polini (Pisa (PI), Italy), D. Nieri (Pisa (PI), Italy), V. Scalise (Pisa (PI), Italy), C. Sanguinetti (Pisa (PI), Italy), I. Passalacqua (Pisa (PI), Italy), R. Pedrinelli (Pisa (PI), Italy), P. Paggiaro (Pisa (PI), Italy), P. Nieri (Pisa (PI), Italy), A. Celi (Pisa (PI), Italy)
Prediction of human orthologs to the Drosophila’s COPD-associated genes. E. Rouka (Larissa, Greece), C. Hatzoglou (Larissa, Greece), K. Gourgoulianis (Larissa, Greece), S. Zarogiannis (Larissa, Greece)
LSC - 2020 - Longitudinal effect of smoking cessation on transcriptomics and epigenetics in the airways of COPD patients and asymptomatic controls A. Faiz (Ultimo (NSW), Australia)
Biomarkers to predict FEV1 decline in smokers and early-onset COPD. C. Gotera (Madrid, Spain), A. Pereira Vega (Huelva, Spain), T. García Barrera (Huelva, Spain), J. Marín Trigo (Zaragoza, Spain), C. Casanova Macario (Santa Cruz De Tenerife., Spain), B. García-Cosío Piqueras (Palma de Mallorca, Spain), I. Mir Viladrich (Palma de Mallorca, Spain), I. Solanes García (Barcelona, Spain), J. Gómez Ariza (Huelva, Spain), J. López Campos (Sevilla, Spain), L. Seijo Maceiras (Madrid, Spain), N. Feu Collado (Córdoba, Spain), C. Cabrera López (Las Palmas De Gran Canarias, Spain), C. Amado Diago (Santander, Spain), A. Romero Plaza (Manacor, Spain), J. De Torres Tajes (Pamplona, Spain), L. Padrón Fraysse (Huelva, Spain), E. Márquez Martín (Sevilla, Spain), M. Marín Royo (Castellón., Spain), E. Balcells Vilarnau (Barcelona, Spain), A. Llunell Casanovas (Barcelona, Spain), C. Martínez González (Oviedo, Spain), J. Galdiz Iturri (Baracaldo, Spain), C. Lacárcel Bautista (Jaén, Spain), S. García Garrido (Huelva, Spain), G. Peces-Barba (Madrid, Spain)
Versatile workflow for storage, characterization and cell-type resolved transcriptional and epigenetic profiles of human lung samples (LSC-2020). M. Llamazares (Heidelberg, Germany), E. Espinet (Heidelberg, Germany), V. Mijosek (Heidelberg, Germany), U. Schwartz (Heidelberg, Germany), S. Waszak (Heidelberg, Germany), P. Lustik (Heidelberg, Germany), R. Tamas (Heidelberg, Germany), M. Richter (Heidelberg, Germany), A. Behrendt (Heidelberg, Germany), S. Pohl (Heidelberg, Germany), N. Benz (Heidelberg, Germany), T. Muley (Heidelberg, Germany), A. Warth (Heidelberg, Germany), C. Heußel (Heidelberg, Germany), F. Hearth (Heidelberg, Germany), T. Mertens (Houston, United States of America), H. Karmouty-Quintana (Houston, United States of America), I. Koch (Munich, Germany), V. Benes (Heidelberg, Germany), J. Korbel (Heidelberg, Germany), A. Trumpp (Heidelberg, Germany), D. Wyatt (Biberach, Germany), H. Stahl (Biberach, Germany), C. Plass (Heidelberg, Germany), R. Jurkowska (Heidelberg, Germany)
MicroRNA-26a expression in exhaled breath condensate correlates with pulmonary exacerbation in cystic fibrosis Z. Stachowiak (Poznan, Poland), I. Wojsyk-Banaszak (Poznan, Poland), K. Jonczyk-Potoczna (Poznan, Poland), J. Gozdzik-Spychalska (Poznan, Poland), K. Sobczak (Poznan, Poland), B. Narozna (Poznan, Poland), A. Breborowicz (Poznan, Poland), A. Szczepankiewicz (Poznan, Poland)
Glucocorticoid signaling genes are altered in asthma subgroups – A potential role for mRNA-miRNA interactions J. Weidner (Göteborg, Sweden), C. Malmhäll (Göteborg, Sweden), A. Barrett (Göteborg, Sweden), H. Hasan (Göteborg, Sweden), E. Boberg (Göteborg, Sweden), L. Ekerljung (Göteborg, Sweden), M. Rådinger (Göteborg, Sweden)
RNA sequencing in bronchial biopsies of wheezing infants developing asthma at school age reveals epithelial dysfunction E. Kersten (Groningen, Netherlands), K. Malmström (Helsinki, Finland), C. Vermeulen (Groningen, Netherlands), C. Xu (Hannover, Germany), M. Van Den Berge (Groningen, Netherlands), W. Timens (Groningen, Netherlands), M. Nawijn (Groningen, Netherlands), M. Mäkelä (Helsinki, Finland), G. Koppelman (Groningen, Netherlands)
Osteopontin and interleukin-6 as biomarkers of interstitial lung disease S. REMUZGO MARTINEZ (SANTANDER, Spain), D. Iturbe Fernández (SANTANDER, Spain), V. Mora Cuesta (SANTANDER, Spain), F. Genre (SANTANDER, Spain), V. Pulito-Cueto (SANTANDER, Spain), S. Fernández Rozas (SANTANDER, Spain), L. Lera-Gómez (SANTANDER, Spain), B. Atienza-Mateo (SANTANDER, Spain), R. López-Mejías (SANTANDER, Spain), M. González-Gay (SANTANDER, Spain), J. Cifrián (SANTANDER, Spain)
Lung function decline in patients with alpha1-antitripsin heterozygosis: preliminary data P. Gaboardi (Milano (MI), Italy), E. Franceschi (Milano (MI), Italy), A. Cristiano (Milano (MI), Italy), A. Airoldi (Milano (MI), Italy), M. Rizzi (Milano (MI), Italy), D. Radovanovic (Milano (MI), Italy), P. Santus (Milano (MI), Italy)
PiS and PiS-plus alleles. The importance of phasing gene variants in Alpha-1 Antitrypsin Deficiency N. Matamala (Madrid, Spain), G. Gomez-Mariano (Madrid, Spain), J. Perez (Canarias, Spain), B. Baladron (Madrid, Spain), M. Torres-Durán (Vigo, Spain), F. Michel (Donostia, Spain), R. Saez (Donostia, Spain), J. Hernández-Pérez (Canarias, Spain), I. Belmonte (Barcelona, Spain), F. Rodriguez-Frias (Barcelona, Spain), I. Blanco (Barcelona, Spain), P. Strnad (Aachen, Germany), S. Janciauskiene (Hannover, Germany), B. Martinez-Delgado (Madrid, Spain)